The massachusetts general hospital substance use disorder initiative will provide multidisciplinary, trauma-informed, dyadic-based, longitudinal medical and mental healthcare in its hope clinic, aimed…

The Massachusetts General Hospital (MGH) Substance Use Disorder Initiative is a $749,939 Project Grant awarded by the U.S. Department of Justice Office of Juvenile Justice and Delinquency Prevention under the Opioid Affected Youth Initiative (CFDA 16.842). The initiative will provide multidisciplinary, trauma-informed, dyadic-based, longitudinal medical and mental healthcare at MGH's HOPE Clinic, aimed at reducing the intergenerational transmission of substance use and minimizing future juvenile justice involvement. The project aims to improve outcomes for parents, infants, and youth impacted by parental opioid and other substance use by integrating the medical and mental healthcare of parents into the care for infants and young children to improve family well-being. The 3-year project period runs from October 1, 2023 to September 30, 2026.

The massachusetts general hospital substance use disorder initiative will provide multidisciplinary, trauma-informed, dyadic-based, longitudinal medical and mental healthcare in its hope clinic, aimed at reducing the intergenerational transmission of substance use and minimizing future juvenile justice involvement. The proposed project aims to improve outcomes for parents, infants, and youth impacted by parental opioid and other substance use by using a bigenerational lens that acknowledges the prenatal period as a critical period for child development and that the medical and mental healthcare of parents can be integrated into the care for infants and young children to improve family well-being.